Trial intelligence / Profile preview

Effect of SGLT-2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes

TCTR20180713001Phase 4Completed

Sponsor
Phramongkutklao Hospital and College of Medicine
Start
Jan 2015
Countries
1
01

Overview

Phase 4, randomised trial in type 2 diabetes mellitus (T2DM), sponsored by Phramongkutklao Hospital and College of Medicine. Started Jan 2015; status: completed.

02

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on TCTR20180713001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180713001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call